AUGUSTA UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1828-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.augusta.edu
Nexplanon Removal: Subcutaneous vs. Topical Lidocaine
Phase 4
- Conditions
- Contraception
- Interventions
- Drug: Subcutaneous Lidocaine
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 40
- Registration Number
- NCT04467125
- Locations
- 🇺🇸
Augusta University Ob/Gyn Resident Continuity Clinic, Augusta, Georgia, United States
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
- First Posted Date
- 2020-06-26
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 24
- Registration Number
- NCT04449198
- Locations
- 🇺🇸
Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology, Augusta, Georgia, United States
Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 1054
- Registration Number
- NCT04386577
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States
Contribution of Dolutegravir to Obesity and Cardiovascular Disease
Phase 4
Completed
- Conditions
- Cardiovascular AbnormalitiesHIV-1-infectionAntiviral Drug Adverse ReactionAbnormality of Adipose TissueVascular DiseasesBody Fat DisorderBody Weight ChangesHIV-Associated Lipodystrophy Syndrome
- Interventions
- Drug: Antiretroviral/Anti HIV
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 10
- Registration Number
- NCT04340388
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
9-valent HPV Vaccine in Postpartum Women
Phase 4
- Conditions
- Human Papilloma Virus
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 100
- Registration Number
- NCT04311528
Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation
Not Applicable
Recruiting
- Conditions
- Chronic SDH and the Efficacy of Embolization
- Interventions
- Procedure: Craniotomy onlyProcedure: Craniotomy + Endovascular embolization of the middle meningeal vessels
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 60
- Registration Number
- NCT04272996
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Video-based Collaborative Learning to Improve Ventral Hernia Repair
Not Applicable
Recruiting
- Conditions
- Ventral Hernia
- Interventions
- Other: CoachingOther: Constructive Feedback
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 54
- Registration Number
- NCT04173884
- Locations
- 🇺🇸
University of Wisconsin-Madison, Madison, Wisconsin, United States
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Phase 1
Terminated
- Conditions
- Non Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerUrothelial CarcinomaMalignant Mesothelioma
- Interventions
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 9
- Registration Number
- NCT04173338
- Locations
- 🇺🇸
Augusta University Georgia Cancer Center, Augusta, Georgia, United States
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Phase 1
Terminated
- Conditions
- Small Cell Lung CarcinomaSmall-cell Lung Cancer
- Interventions
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 10
- Registration Number
- NCT04173325
- Locations
- 🇺🇸
Georgia Cancer Center at AU Medical Center, Augusta, Georgia, United States
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men
Not Applicable
- Conditions
- TransgenderismCervical CancerHuman Papilloma Virus
- Interventions
- Diagnostic Test: HPV testing
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 100
- Registration Number
- NCT04154358
© Copyright 2025. All Rights Reserved by MedPath